Rituxan Hycela Interactions
There are 284 drugs known to interact with Rituxan Hycela (hyaluronidase/rituximab), along with 7 disease interactions. Of the total drug interactions, 53 are major, 144 are moderate, and 87 are minor.
- View all 284 medications that may interact with Rituxan Hycela
- View Rituxan Hycela disease interactions (7)
Most frequently checked interactions
View interaction reports for Rituxan Hycela (hyaluronidase / rituximab) and the medicines listed below.
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Aspirin Low Strength (aspirin)
- Bendeka (bendamustine)
- Blenoxane (bleomycin)
- bleomycin
- Bosulif (bosutinib)
- Braftovi (encorafenib)
- Caprelsa (vandetanib)
- Cayston (aztreonam)
- Esbriet (pirfenidone)
- fluoxetine
- folic acid
- Givlaari (givosiran)
- Imbruvica (ibrutinib)
- Invirase (saquinavir)
- Kalydeco (ivacaftor)
- levothyroxine
- Norvir (ritonavir)
- Novantrone (mitoxantrone)
- Oncovin (vincristine)
- prednisone
- Rebinyn (coagulation factor ix)
- Sandimmune (cyclosporine)
- Tarceva (erlotinib)
- Trizivir (abacavir / lamivudine / zidovudine)
- Truvada (emtricitabine / tenofovir disoproxil)
- Valium (diazepam)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Rituxan Hycela disease interactions
There are 7 disease interactions with Rituxan Hycela (hyaluronidase / rituximab) which include:
- autoimmune diseases
- cardiac dysfunction
- hepatitis B
- TLS
- bone marrow suppression
- infections
- renal impairment
Report options
More about Rituxan Hycela (hyaluronidase / rituximab)
- Rituxan Hycela consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Lenalidomide
Lenalidomide (Revlimid) is used to treat multiple myeloma, mantle cell lymphoma, follicular ...
Vincristine
Vincristine is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
